US Large Cap Value Stocks to Watch in September 2025

The US stock market is always a hotbed of investment opportunities, especially when it comes to large cap value stocks. As we approach September 2025, investors are increasingly looking to capitalize on undervalued blue-chip companies. This article delves into the most promising large cap value stocks to watch in September 2025, highlighting key trends and offering insightful analysis.

Understanding Large Cap Value Stocks

Large cap value stocks are shares of companies with a market capitalization of $10 billion or more, known for their stability and reliable earnings. These stocks often trade at a price-to-earnings (P/E) ratio below the market average, indicating that they are undervalued. September 2025 presents a unique opportunity for investors to identify undervalued large cap value stocks and potentially reap substantial returns.

Top Large Cap Value Stocks to Watch

1. Procter & Gamble (PG)

Procter & Gamble (NYSE: PG) is a consumer goods giant with a market capitalization of over $300 billion. The company boasts a diverse portfolio of brands, including Tide, Pampers, and Gillette. Despite the challenging economic environment, PG has remained resilient and continues to deliver consistent earnings. Its P/E ratio of around 20 is significantly below the market average, making it an attractive value investment.

2. Coca-Cola (KO)

Coca-Cola (NYSE: KO) is another top large cap value stock with a market capitalization exceeding $250 billion. The world's largest beverage company has a strong global presence and a wide array of iconic brands. With a P/E ratio of around 23, Coca-Cola is slightly undervalued, offering investors an attractive entry point.

3. Johnson & Johnson (JNJ)

Johnson & Johnson (NYSE: JNJ) is a diversified healthcare giant with a market capitalization of over $400 billion. The company has a strong track record of innovation and operates in various segments, including pharmaceuticals, consumer healthcare, and medical devices. JNJ's P/E ratio of around 30 is well below the market average, making it a compelling value investment.

4. IBM (IBM)

IBM (NYSE: IBM) is a technology giant with a market capitalization of over $150 billion. The company offers a wide range of IT services, including cloud computing, artificial intelligence, and cybersecurity. With a P/E ratio of around 15, IBM is significantly undervalued, offering investors a great opportunity for long-term growth.

5. Pfizer (PFE)

Pfizer (NYSE: PFE) is a pharmaceutical giant with a market capitalization of over $200 billion. The company has a strong pipeline of new drug approvals and operates in various therapeutic areas. Its P/E ratio of around 18 is below the market average, making it an appealing value investment.

Case Studies

*Procter & Gamble (PG): In the first half of 2025, PG reported earnings per share of 1.53, a 3% increase from the same period in 2024. The company also raised its dividend by 4.5%, reflecting its commitment to shareholder value. Coca-Cola (KO): In 2025, Coca-Cola reported global revenue of 54 billion, a 6% increase from 2024. The company's strong performance in emerging markets contributed significantly to this growth.

Conclusion

September 2025 is shaping up to be an exciting time for investors looking to invest in large cap value stocks. The aforementioned companies offer a combination of stability, reliable earnings, and undervalued share prices, making them compelling investments for long-term growth. As always, it is essential for investors to conduct thorough research and consult with a financial advisor before making any investment decisions.

American Stock exchange